In its role as the voice for the drug and alcohol testing industry, one of the National Drug and Alcohol Screening Association’s priorities is to provide input representing members’ interests concerning drug and alcohol testing regulations. On April 20, NDASA...
DOT
How can we help?
Featured posts
All posts
Oral Fluid Testing: Soon, But Not Yet
Since the new 2020 U.S. Department of Transportation Custody and Control Form became available in September, one tiny addition has created a tremendous amount of confusion among employers, specimen collectors and others involved in DOT-mandated drug screening. The...
NDASA Wins One for Public Safety
The National Drug & Alcohol Screening Association has had a major win today with language added to the MORE ACT that allows continued marijuana drug testing for DOT safety-sensitive workers! The MORE Act is an attempt to remove marijuana from the list of federally...
The New Normal: How to ensure compliance during COVID-19
In recent weeks, the National Drug & Alcohol Screening Association (NDASA) has hosted a series of COVID-19 Townhall Discussions for its members in the drug and alcohol screening industry. The main takeaways from these meetings? Our members are passionate...
NDASA Guidance and U.S. DOT Response to COVID-19
In light of recent reports that the Federal Motor Carriers Safety Administration (FMCSA) and other transportation modes are considering suspending random drug testing requirements during the COVID-19 health crisis, the National Drug and Alcohol Screening...
Search this site
Stay in touch
Give to NDASA
Latest News & Updates
- Jun 08, 2022Where Are We and Where Are We Going? The State of Drug Testing and the Future
- Jun 07, 2022NDASA Responds to SAMHSA Proposed Rules for Oral Fluid Testing in Federal Workplaces
- Jun 07, 2022The Great Retention: How to Hold onto Your Most Valuable Asset, Your Employees
- Jun 07, 2022First-Time Conference Attendee Vows to Return
- Jun 02, 2022Conference 2022: Three Days Packed With Teaching, Learning, Business Building and Progress
Topics We Track
- Advocacy (3)
- Business Development (1)
- Committee Reports (1)
- DOT (5)
- Drug & Alcohol Testing (19)
- Drug Legislation (8)
- Feature (50)
- FMCSA (3)
- For Drug Testing Industry Professionals (14)
- For Employers and Workplace Safety & Wellness Professionals (12)
- Industry News (10)
- Marijuana & CBD (13)
- Member Benefits (1)
- Membership (3)
- NDASA Conference (10)
- NDASA Guidance (4)
- Opioids (2)
- Resources (21)
- Substance Use (1)
- Substance Use/Addiction (3)
- Training (1)
- Uncategorized (7)
- Workplace Safety (4)